T 0360/09 (Albumin fraction/OCTAPHARMA) of 06.06.2013
- European Case Law Identifier
- ECLI:EP:BA:2013:T036009.20130606
- Date of decision
- 6 June 2013
- Case number
- T 0360/09
- Petition for review of
- -
- Application number
- 03767649.1
- IPC class
- A61K 38/38
- Language of proceedings
- English
- Distribution
- Distributed to board chairmen (C)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Prekallikrein depleted plasma derived albumin fraction
- Applicant name
- Octapharma AG
- Opponent name
- NHS Blood and Transplant (Gwaed a Thrawsblaniadau'r GIG)
CSL Behring GmbH
Baxter Aktiengesellschaft
Stichting Sanquin Bloedvoorziening
Biotest AG - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- EPC2000_Art_108_Sent_3European Patent Convention Art 108European Patent Convention R 99(2)
- Keywords
- Admissibility of the appeal (no) - insufficient substantiation
- Catchword
- See points 1.1-10.2
- Citing cases
- -
ORDER
For these reasons it is decided that:
The appeal is rejected as inadmissible.